|
1
|
Yuan XJ, Wang HM, Jiang H, Tang MJ, Li ZL,
Zou X, Fang YJ, Pan C, Tou JF, Zhang KR, et al: Multidisciplinary
effort in treating children with hepatoblastoma in China. Cancer
Lett. 375:39–46. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
van As JW, van den Berg H and van Dalen
EC: Medical interventions for the prevention of platinum-induced
hearing loss in children with cancer. Cochrane Database Syst Rev.
9:CD0092192016.PubMed/NCBI
|
|
3
|
Zhu S, Pabla N, Tang C, He L and Dong Z:
DNA damage response in cisplatin-induced nephrotoxicity. Arch
Toxicol. 89:2197–2205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fujikawa Y, Kawanishi M, Kuraoka I and
Yagi T: Frequencies of mutagenic translesion DNA synthesis over
cisplatin-guanine intra-strand crosslinks in lacZ plasmids
propagated in human cells. Mutat Res Genet Toxicol Environ Mutagen.
770:23–28. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chipuk JE, Kuwana T, Bouchier-Hayes L,
Droin NM, Newmeyer DD, Schuler M and Green DR: Direct activation of
Bax by p53 mediates mitochondrial membrane permeabilization and
apoptosis. Science. 303:1010–1014. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vondálová Blanárová O, Jelínková I, Szöor
A, Skender B, Soucek K, Horváth V, Vaculová A, Andera L, Sova P,
Szöllosi J, et al: Cisplatin and a potent platinum(IV)
complex-mediated enhancement of TRAIL-induced cancer cells killing
is associated with modulation of upstream events in the extrinsic
apoptotic pathway. Carcinogenesis. 32:42–51. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhu X, Zhang K, Wang Q, Chen S, Gou Y, Cui
Y and Li Q: Cisplatin-mediated c-Myc overexpression and cytochrome
c (cyt c) release result in the up-regulation of the death
receptors DR4 and DR5 and the activation of caspase-3 and caspase
9, likely responsible for the TRAIL-sensitizing effect of
cisplatin. Med Oncol. 32:1332015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Song JH, Tse MC, Bellail A, Phuphanich S,
Khuri F, Kneteman NM and Hao C: Lipid rafts and non-rafts mediate
tumor necrosis factor related apoptosis-inducing ligand induced
apoptotic and nonapoptotic signals in non small cell lung carcinoma
cells. Cancer Res. 67:6946–6955. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Paul I, Chacko AD, Stasik I, Busacca S,
Crawford N, McCoy F, McTavish N, Wilson B, Barr M, O'Byrne KJ, et
al: Acquired differential regulation of caspase-8 in
cisplatin-resistant non-small-cell lung cancer. Cell Death Dis.
3:e4492012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yeang C, Ding T, Chirico WJ and Jiang XC:
Subcellular targeting domains of sphingomyelin synthase 1 and 2.
Nutr Metab (Lond). 8:892011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Taniguchi M and Okazaki T: The role of
sphingomyelin and sphingomyelin synthases in cell death,
proliferation and migration-from cell and animal models to human
disorders. Biochim Biophys Acta. 1841:692–703. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Slotte JP: Biological functions of
sphingomyelins. Prog Lipid Res. 52:424–437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
López-Terrada D, Cheung SW, Finegold MJ
and Knowles BB: Hep G2 is a hepatoblastoma-derived cell line. Hum
Pathol. 40:1512–1515. 2009. View Article : Google Scholar
|
|
14
|
Yan N, Ding T, Dong J, Li Y and Wu M:
Sphingomyelin synthase overexpression increases cholesterol
accumulation and decreases cholesterol secretion in liver cells.
Lipids Health Dis. 10:462011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Huang CR, Jin ZX, Dong L, Tong XP, Yue S,
Kawanami T, Sawaki T, Sakai T, Miki M, Iwao H, et al: cisplatin
augments FAS-mediated apoptosis through lipid rafts. Anticancer
Res. 30:2065–2071. 2010.PubMed/NCBI
|
|
16
|
Luberto C and Hannun YA: Sphingomyelin
synthase, a potential regulator of intracellular levels of ceramide
and diacylglycerol during SV40 transformation. Does sphingomyelin
synthase account for the putative phosphatidylcholine-phospholipase
C. J Biol Chem. 273:14550–14559. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sumi T, Tsuneyoshi N, Nakatsuji N and
Suemori H: Apoptosis and differentiation of human embryonic stem
cells induced by sustained activation of c-Myc. Oncogene.
26:5564–5576. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Burns TA, Subathra M, Signorelli P, Choi
Y, Yang X, Wang Y, Villani M, Bhalla K, Zhou D and Luberto C:
Sphingomyelin synthase 1 activity is regulated by the BCR-ABL
oncogene. J Lipid Res. 54:794–805. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wesley UV, Hatcher JF and Dempsey RJ:
Sphingomyelin synthase 1 regulates Neuro-2a cell proliferation and
cell cycle progression through modulation of p27 expression and Akt
signaling. Mol Neurobiol. 51:1530–1541. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kim DY, Kim MJ, Kim HB, Lee JW, Bae JH,
Kim DW, Kang CD and Kim SH: Suppression of multidrug resistance by
treatment with TRAIL in human ovarian and breast cancer cells with
high level of c-Myc. Biochim Biophys Acta. 1812:796–805. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kondo K, Yamasaki S, Sugie T, Teratani N,
Kan T, Imamura M and Shimada Y: Cisplatin-dependent upregulation of
death receptors 4 and 5 augments induction of apoptosis by
TNF-related apoptosis-inducing ligand against esophageal squamous
cell carcinoma. Int J Cancer. 118:230–242. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ding T, Li Z, Hailemariam T, Mukherjee S,
Maxfield FR, Wu MP and Jiang XC: SMS overexpression and knockdown:
Impact on cellular sphingomyelin and diacylglycerol metabolism, and
cell apoptosis. J Lipid Res. 49:376–385. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Barceló-Coblijn G, Martin ML, de Almeida
RF, Noguera-Salvà MA, Marcilla-Etxenike A, Guardiola-Serrano F,
Lüth A, Kleuser B, Halver JE and Escribá PV: Sphingomyelin and
sphingomyelin synthase (SMS) in the malignant transformation of
glioma cells and in 2-hydroxyoleic acid therapy. Proc Natl Acad
Sci. 108:pp. 19569–19574. 2011; View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Simons K and Ikonen E: Functional rafts in
cell membranes. Nature. 387:569–572. 1997. View Article : Google Scholar : PubMed/NCBI
|
